Valneva
Saint-herblain
About Valneva
Valneva is a pharmaceutical company developing prophylactic vaccines to treat infectious diseases. The company focused on developing and commercializing prophylactic vaccines for infectious diseases with significant unmet medical needs. Valneva has leveraged its expertise and capabilities both to commercialize two vaccines successfully and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus, and COVID-19.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Total funding: $1.1B
- Funding stage: IPO
- Last round: Post-IPO Debt (Oct 2025)
- Ticker: epa:VLA
- Website: valneva.com
- Phone: 33 2 28 07 37 10
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/valneva-17430 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.